Clinical Trials Sponsored by Orla Deegan

Total 335 results

LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia (CLARITY)

Eye Diseases | Refractive Error | Presbyopia | Miosis | Near Vision

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle

Allergic Conjunctivitis

United States
Faes Farma, S.A.
ORA, Inc.

Completed

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Allergic Conjunctivitis

United States
Allgenesis Biotherapeutics Inc.
ORA, Inc.

Completed

A Study of AG-80308 in Dry Eye Patients

Dry Eye Disease

United States
BRIM Biotechnology Inc.
ORA, Inc.

Completed

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

Dry Eye Syndrome

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness

Hyperemia

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
Rhodes Pharmaceuticals, L.P.
ORA, Inc.

Completed

Safety and Efficacy of PG101 for Dry Eye Syndrome (PG101)

Dry Eye Syndrome

United States
Stuart Therapeutics, Inc.
ORA, Inc.

Completed

Study of ST-100 as Treatment for Dry Eye Disease

Dry Eye Disease

United States
ORA, Inc.
Topivert Pharma Ltd

Completed

Safety and Efficacy of TOP1630 for Dry Eye Syndrome

Dry Eye Syndrome

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia

Eye Diseases | Refractive Errors | Presbyopia

United States
ORA, Inc.
Tufts Medical Center

Completed

Food Allergy Challenge Diagnostic Study

Food Hypersensitivity

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

Dry Eye
Woodmont Pharmaceuticals, Inc.
ORA, Inc.

Terminated

Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

Allergic Rhinitis | Allergic Conjunctivitis

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.

Hyperemia

United States
Deacon Biosciences, Inc.
ORA, Inc.

Completed

A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Ocular Infection

United States
Deepa Jagadeesh

Terminated

Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder

Post-transplant Lymphoproliferative Disorder

United States
Megan Petrov

Terminated

Internet Cognitive Behavioral Therapy for Insomnia to Prevent Cardiovascular Disease (STOPCVD)

Insomnia Chronic | Subclinical Disease and/or Syndrome

United States
German Association of Oral Implantology e. V.

Completed

Cross-sectional Examination of the Reliability of Oral Implants (PeriX2012)

Periimplantitis

Germany
Bispebjerg Hospital
University of Copenhagen; Arla Foods

Completed

Effect of Strength Training and Protein Ingestion in Old Versus Very-old

Sarcopenia | Muscle Loss

Denmark
Atlantic Center for Oral and Maxillofacial Surgery

Unknown

Orthognathic Surgery and Postoperative Antibiotic Use

Dentofacial Deformity

Canada
University of Copenhagen
Lundbeck Foundation; Arla Foods

Completed

Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.

Obesity | Insulin Resistance

Denmark
Bispebjerg Hospital
University of Copenhagen; Arla Foods

Completed

Counteracting Age-related Loss of Skeletal Muscle Mass (CALM) (CALM)

Sarcopenia | Muscle Loss

Denmark
Muhammet Ayhan ORAL
Hacettepe University

Completed

Turkish Adaptation Of GMFCS Family Report And The Agreement Of Family and Physiotherapist

Cerebral Palsy

Turkey
Universidad Complutense de Madrid
Oral Reconstruction Foundation

Active, not recruiting

One-time Abutment Placement Versus 4 Times Abutment Removal Around Dental Implants

Dental Implant | Prosthetic Abutment

Spain
Bispebjerg Hospital
University of Copenhagen; Arla Foods

Completed

Counteracting Age-related Loss of Skeletal Muscle Mass (CALM)

Sarcopenia | Muscle Loss

Denmark
University of Aarhus
Arla Food for Health

Completed

Whey vs Casein to Combat Post-inflammatory Protein and Muscle Waste in Acute Disease

Endotoxemia | Muscle Protein Synthesis | Nutrition | Metabolism | Milk Protein | Whey | Casein

Denmark
University of Copenhagen
Arla Foods; Slagelse Hospital

Completed

Increased Focus on Protein Intake Among Geriatric Patients

Geriatric Diseases

Denmark
Atlantic Center for Oral and Maxillofacial Surgery

Unknown

Safety and Efficacy of Propofol Only Sedation in Oral and Maxillofacial Surgery

Propofol | Procedural Sedation

Canada
ORA, Inc.
Stuart Therapeutics, Inc.

Recruiting

Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)

Dry Eye Disease

United States
Neuracle Genetics, Inc
ORA, Inc.

Recruiting

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Age-Related Macular Degeneration

Canada
2C Tech Corp
ORA, Inc.

Not yet recruiting

Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)

Retinitis Pigmentosa
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Safety Study for the Treatment of Presbyopia Subjects

Eye Diseases | Presbyopia | Miosis | Near Vision

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia (CLARITY)

Eye Diseases | Presbyopia | Miosis | Near Vision

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Eye Diseases | Refractive Errors | Presbyopia | Ophthalmic Solutions | Brimonidine Tartrate | Aceclidine

United States
Faes Farma, S.A.
ORA, Inc.

Completed

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

Allergic Conjunctivitis

United States
Aldeyra Therapeutics, Inc.
ORA, Inc.

Completed

A Study of ADX-102 in Subjects With Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
ORA, Inc.
Palatin Technologies, Inc

Completed

Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye

Dry Eye Disease

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants

Hyperemia

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
Nicox Ophthalmics, Inc.
ORA, Inc.

Completed

A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Healthy Subjects

United States
3E Therapeutics Corporation
ORA, Inc.

Completed

Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

Seasonal Allergic Rhinitis
Herantis Pharma Plc.
ORA, Inc.

Completed

Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye

Dry Eye Syndrome

United States
Eye Therapies, LLC
ORA, Inc.

Completed

A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)

Allergic Conjunctivitis

United States
University of the Aegean
E.Thimelis Dairy S.A.

Completed

Investigation of the Postprandial Response of Two Different PDO Cheeses on Metabolic Biomarkers (LadotyriCT)

Healthy

Greece
Dean Health System

Completed

Intraocular Steroid After Cataract Surgery Study

Cataract

United States
Deepa Jagadeesh

Recruiting

A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)

Angioimmunoblastic T-cell Lymphoma | T-cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Enteropathy Associated T-cell Lymphoma | Hepato-splenic T-cell Lymphoma | NK T-cell Lymphoma

United States
Devan Parrott

Completed

Brain Injury Coping Skills - Telemedicine: Phase II (BICS-T-2)

Traumatic Brain Injury | Coping Skills | Caregivers

United States
Chatham University
Megan J. Olson Hunt

Completed

A Comparison of Seated Thoracic Manipulation and Targeted Supine Thoracic Manipulation on Cervical Flexion Motion and Pain

Neck Pain

Clinical Trials Sponsored by Orla Deegan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations